Inflammatory Markers and Procoagulants in Chronic Renal Disease Stages 1-4

Alma Muslimovic1, Senija Rasic1, Denijal Tulumovic2

  • 1Clinic of Nephrology, University Clinical Center Sarajevo, Sarajevo, Bosnia and Herzegovina.

Insights

Chronic kidney disease (CKD) progression is linked to increased inflammation and clotting markers. Monitoring these inflammatory and procoagulant markers may aid in predicting cardiovascular risk in CKD patients.

Area of Science:

  • Nephrology
  • Cardiovascular Medicine
  • Clinical Chemistry

Background:

  • Chronic kidney disease (CKD) is a progressive condition characterized by inflammation and a hypercoagulable state.
  • This inflammatory and procoagulant state contributes to the high rates of cardiovascular morbidity and mortality observed in CKD patients.

Purpose of the Study:

  • To monitor key inflammatory and procoagulant markers across various stages (1-4) of chronic kidney disease.
  • To investigate the association between CKD progression and these biochemical markers.

Main Methods:

  • Inclusion of 120 adult subjects with CKD stages 1-4 over a 24-month period.
  • Laboratory analysis included serum creatinine, albumin, C-reactive protein (CRP), leukocytes, plasma fibrinogen, D-dimer, antithrombin III, coagulation factors VII (FC VII), and coagulation factor VIII (FC VIII).

Main Results:

  • Significant increases in CRP, fibrinogen, and FC VIII were observed with CKD progression (stages 1-4).
  • Leukocyte counts increased, and antithrombin III levels decreased, though not always statistically significant.
  • No significant differences were found in D-dimer and FC VII values across CKD stages.

Conclusions:

  • CKD progression is significantly associated with heightened inflammation.
  • These inflammatory markers hold potential for prognostic and therapeutic applications in managing CKD.
  • The established link between inflammation and cardiovascular risk suggests these biomarkers could predict outcomes and benefit early diagnosis/treatment of cardiovascular disease in CKD patients.
Abstract

Related Concept Videos

Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
487
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
621
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
1.1K
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
947
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
1.4K
Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
1.9K